Scopolamine Market Size, Share & Trends Analysis Report By Dosage Form (Injectables, Tablet, Transdermal Patches, And Other Dosage Forms), By Distribution Channel, And Region Forecasts, 2023 - 2030

Scopolamine Market Size & Trends

The global scopolamine market size was valued at USD 385 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The rising incidence of motion sickness and the increasing population of geriatrics are anticipated to boost the demand for scopolamine over the forecast period. Scopolamine is extensively utilized to prevent nausea and vomiting linked with motion sickness, chemotherapy, and surgery. Consequently, with the rising awareness in healthcare and an increasing demand for potent antiemetic drugs, the scopolamine market is projected to experience growth in the coming years.

Scopolamine can also be used in the treatment of specific gastrointestinal conditions, including spastic muscle states, irritable bowel syndrome, and diverticulitis, among others. Moreover, increasing treatment trials on the drug to identify potential new applications have spurred the market growth. Recently, many studies have reported the use of scopolamine for the treatment of depressive disorders. According to an article published in the International Journal of Psychiatry in April 2021, most of the recent treatment trials on scopolamine have confirmed the antidepressant effects of the drug on unipolar and bipolar depression, wherein scopolamine was used as an alternative to ketamine in patients suffering from treatment-resistant depression.

In August 2022, Southwest Research Institute established an effective, entirely synthetic technique for the production of scopolamine. This compound, derived from plants, is widely used to combat nausea and vomiting associated with motion sickness and anesthesia. This breakthrough represents the initial occurrence where SwRI has completely synthesized a pharmaceutical compound derived from botanical sources. Thus, these advancements in research and clinical investigations are propelling the scopolamine market forward.

Please note The report will be delivered in 2-3 business days upon order notification.